Psychopharmacology of chronic pain: a focus on antidepressants and atypical antipsychotics

References

• Barsky AJ, Peekna HM, Borus JF. Somatic symptom reporting in women and men. J Gen Intern Med. 2001;16:266–275.
   PubMed Web of Science ®Google Scholar
• Krebs EE, Carey TS, Weinberger M. Accuracy of the pain numeric rating scale as a screening test in primary care. J Gen Intern Med. 2007;22:1453–1458.
   PubMed Web of Science ®Google Scholar
• Lohman D1, Schleifer R, Amon JJ. Access to pain treatment as a human right. BMC Med. 2010;8:8.
   PubMed Web of Science ®Google Scholar
• World Health Organization. Briefing note: access to controlled medications programme. Geneva: WHO; 2008.
   Google Scholar
• American Academy of Pain Medicine, Dubois MY, Rollin M, et al. Editors. Ineffective pain care costing over $100 billion annually. Pain Medicine Position Paper. 2009;10–27.
   Google Scholar
• Centers for Medicare & Medicaid Services. National health expenditure accounts. Historical. Available from: http://www.cms.hhs.gov/NationalHealthExpendData.
   Google Scholar
• Kwon JH, Tanco K, Hui D, et al. Chemical coping versus pseudoaddiction in patients with cancer pain. Palliat Support Care. 2014;12:413–417.
   PubMed Web of Science ®Google Scholar
• Trang T, Al-Hasani R, Salvemini D, et al. Pain and poppies: the good, the bad, and the ugly of opioid analgesics. J Neurosci. 2015;35:13879–13888.
   PubMed Web of Science ®Google Scholar
• Ciaramella A. Poli chronic low back pain: perception and coping with pain in the presence of psychiatric comorbidity. J Nerv Ment Dis. 2015;203:632–640.
   PubMed Web of Science ®Google Scholar
• Gros DF, Szafranski DD, Brady KT, et al. Relations between pain, PTSD symptoms, and substance use in veterans. Psychiatry. 2015;78:277–287.
   PubMed Web of Science ®Google Scholar
• Uçar M, Sarp Ü, Karaaslan Ö, et al. Health anxiety and depression in patients with fibromyalgia syndrome. J Int Med Res. 2015;43:679–685.
   PubMed Web of Science ®Google Scholar
• Beesdo K, Jacobi F, Hoyer J, et al. Pain associated with specific anxiety and depressive disorders in a nationally representative population sample. Soc Psychiatry Psychiatr Epidemiol. 2010;45(1):89–104.
   PubMed Web of Science ®Google Scholar
• Khouzam HR. Chronic fatigue syndrome. An update on treatment in primary care. Consultant. 2011;51:145–150.
   Google Scholar
• Merskey H, Bogduk N, editors. International Association for the Study of Pain. Classification of chronic pain: descriptions of chronic pain syndromes and definitions of pain terms. 2nd ed. Seattle (Washington): IASP; 1994.
   Google Scholar
• Dzau VJ, Pizzo PA. Relieving pain in America: insights from an Institute of Medicine committee. JAMA. 2014;312:1507–1508.
   PubMed Web of Science ®Google Scholar
• Bennett M. The LANSS pain scale: the Leeds assessment of neuropathic symptoms and signs. Pain. 2001;92:147–157.
   PubMed Web of Science ®Google Scholar
• Gilron I, Watson CP, Cahill CM, et al. Neuropathic pain: a practical guide for the clinician. CMAJ. 2006;175:265–275.
   PubMed Web of Science ®Google Scholar
• Maier C, Baron R, Tölle TR, et al. Quantitative sensory testing in the German Research Network on Neuropathic Pain (DFNS): Somatosensory abnormalities in 1236 patients with different neuropathic pain syndromes. Pain. 2010;150:439–450.
   PubMed Web of Science ®Google Scholar
• Finnerup NB, Sindrup SH, Jensen TS. The evidence for pharmacological treatment of neuropathic pain. Pain. 2010;150:573–581.
   PubMed Web of Science ®Google Scholar
• Fishbain DA. Evidence-based treatment paradigms for depressed patients with pain and physical symptoms. J Clin Psychiatry. 2009;70(7):e22.
   PubMedGoogle Scholar
• Haanpaa ML, Gourlay GK, Kent JL, et al. Treatment considerations for patients with neuropathic pain and other medical comorbidities. Mayo Clin Proc. 2010;85(3 Suppl):S15–25.
   PubMed Web of Science ®Google Scholar
• Bair MJ, Robinson RL, Katon W, et al. Depression and pain comorbidity: a literature review. Arch Intern Med. 2003;163:2433–2445.
   PubMed Web of Science ®Google Scholar
• Mhalla A, De Andrade DC, Baudic S, et al. Alteration of cortical excitability in patients with fibromyalgia. Pain. 2010;149:495–500.
   PubMed Web of Science ®Google Scholar
• Schnitzler A, Ploner M. Neurophysiology and functional neuroanatomy of pain perception. J Clin Neurophysiol. 2000;17:592–603.
   PubMed Web of Science ®Google Scholar
• Usunoff KG, Popratiloff A, Schmitt O, et al. Functional neuroanatomy of pain. Adv Anat Embryol Cell Biol. 2006;184:1–115.
   PubMed Web of Science ®Google Scholar
• Villemure C, Schweinhardt P. Supraspinal pain processing: distinct roles of emotion and attention. Neuroscientist. 2010;16:276–284.
   PubMed Web of Science ®Google Scholar
• Jann MW, Slade JH. Antidepressant agents for the treatment of chronic pain and depression. Pharmacotherapy. 2007;27:1571–1587.
   PubMed Web of Science ®Google Scholar
• Chaki S, Fukumoto K. Potential of glutamate-based drug discovery for next generation antidepressants. Pharmaceuticals (Basel). 2015;8:590–606.
   PubMedGoogle Scholar
• Fava M. Somatic symptoms, depression, and antidepressant treatment. J Clin Psychiatry. 2002;63:305–307.
   PubMed Web of Science ®Google Scholar
• Rivat C, Becker C, Blugeot A, et al. Chronic stress induces transient spinal neuroinflammation, triggering sensory hypersensitivity and long-lasting anxiety-induced hyperalgesia. Pain. 2010;150:358–368.
   PubMed Web of Science ®Google Scholar
• McHugh JM, McHugh WB. Pain: neuroanatomy, chemical mediators, and clinical implications. AACN Clin Issues. 2000;11:168–178.
   PubMedGoogle Scholar
• D’Andrea G, Leon A. Pathogenesis of migraine: From neurotransmitters to neuromodulators and beyond. Neurol Sci. 2010;31(Suppl 1):S1–7.
   PubMed Web of Science ®Google Scholar
• Ross RL, Jones KD, Bennett RM, et al. Preliminary evidence of increased pain and elevated cytokines in fibromyalgia patients with defective growth hormone response to exercise. Open Immunol J. 2010;3:9–18.
   PubMedGoogle Scholar
• Uceyler N, Kafke W, Riediger N, et al. Elevated proinflammatory cytokine expression in affected skin in small fiber neuropathy. Neurology. 2010;74:1806–1813.
   PubMed Web of Science ®Google Scholar
• Yohannes AM, Caton S. Management of depression in older people with osteoarthritis: A systematic review. Aging Ment Health. 2010;14:637–651.
   PubMed Web of Science ®Google Scholar
• Narasimhan M, Campbell N. A tale of two comorbidities: understanding the neurobiology of depression and pain. Indian J Psychiatry. 2010;52:127–130.
   PubMedGoogle Scholar
• Rodieux F, Piguet V, Berney P, et al. Prescription of antidepressants in the treatment of pain: role of pharmacogenetics. Rev Med Suisse. 2015;11:1374–1379.
   PubMedGoogle Scholar
• Katzman MA, Pawluk EJ, Tsirgielis D, et al. Beyond chronic pain: how best to treat psychological comorbidities. J Fam Pract. 2014;63:260–264.
   PubMed Web of Science ®Google Scholar
• Angst F, Verra ML, Lehmann S, et al. Refined insights into the pain-depression association in chronic pain patients. Clin J Pain. 2008;24:808–816.
   PubMed Web of Science ®Google Scholar
• Rico-Villademoros F, Slim M, Calandre EP. Amitriptyline for the treatment of fibromyalgia: a comprehensive review. Expert Rev Neurother. 2015;15:1123–1150.
   PubMed Web of Science ®Google Scholar
• Shultz E, Malone DA Jr. A practical approach to prescribing antidepressants. Cleve Clin J Med. 2013;80:625–631.
   PubMed Web of Science ®Google Scholar
• Clark MR. Pharmacological treatments for chronic non-malignant pain. Int Rev Psychiatry. 2000;12:148–156.
   Web of Science ®Google Scholar
• Saarto T, Wiffen PJ. Antidepressants for neuropathic pain. Cochrane Database Syst Rev. 2005;3:CD005454.
   PubMedGoogle Scholar
• Littlejohn GO, Guymer EK. Fibromyalgia syndrome: which antidepressant drug should we choose. Curr Pharm Des. 2006;12:3–9.
   PubMed Web of Science ®Google Scholar
• Gershon MD, Tack J. The serotonin signaling system: from basic understanding to drug development for functional GI disorders. Gastroenterology. 2007;132:397–414.
   PubMed Web of Science ®Google Scholar
• Walker EA, Roy-Byrne PP, Katon WJ, et al. An open trial of nortriptyline in women with chronic pelvic pain. Int J Psychiatry Med. 1991;21:245–252.
   PubMed Web of Science ®Google Scholar
• Phatak S, Foster HE. The management of interstitial cystitis: an update. Nat Clin Pract Urol. 2006;3:45–53.
   PubMedGoogle Scholar
• Staiger TO, Gaster B, Sullivan MD, et al. Systematic review of antidepressants in the treatment of chronic low back pain. Spine. 2003;28:2540–2545.
   PubMed Web of Science ®Google Scholar
• Miura N, Saito T, Taira T, et al. Risk factors for QT prolongation associated with acute psychotropic drug overdose. Am J Emerg Med. 2015;33:142–149.
   PubMed Web of Science ®Google Scholar
• Sultana J, Spina E, Trifirò G. Antidepressant use in the elderly: the role of pharmacodynamics and pharmacokinetics in drug safety. Expert Opin Drug Metab Toxicol. 2015;11:883–892.
   PubMed Web of Science ®Google Scholar
• Eschalier A, Ardid D, Dubray C. Tricyclic and other antidepressants as analgesics. In: Sawynok J, Cowan A, editors. Novel aspects of pain management: opioids and beyond. New York (NY): Wiley-Liss; 1999. p. 303–319.
   Google Scholar
• McQuay HJ, Tramér M, Nye BA, et al. A systematic review of antidepressants in neuropathic pain. Pain. 1996;68:217–227.
   PubMed Web of Science ®Google Scholar
• Rintala DH, Holmes SA, Courtade D, et al. Comparison of the effectiveness of amitriptyline and gabapentin in chronic neuropathic pain in persons with spinal cord injury. Arch Phys Med Rehabil. 2007;88:1547–1560.
   PubMed Web of Science ®Google Scholar
• Pancrazio JJ, Kamatchi GL, Roscoe AK, et al. Inhibition of neuronal Na+ channels by antidepressant drugs. J Pharmacol Exp Ther. 1998;284:208–214.
   PubMed Web of Science ®Google Scholar
• Harrigan RA, Brady WJ. ECG abnormalities in tricyclic anti-depressant ingestion. Am J Emerg Med. 1999;17:387–393.
   PubMed Web of Science ®Google Scholar
• Marcus DA. Current trends in fibromyalgia research. Expert Opin Pharmacother. 2003;4:1687–1695.
   PubMed Web of Science ®Google Scholar
• Tack J, Broekaert D, Fischler B, et al. A controlled crossover study of the selective serotonin reuptake inhibitor citalopram in irritable bowel syndrome. Gut. 2006;55:1095–1103.
   PubMed Web of Science ®Google Scholar
• USP. DI volume I: drug information for the healthcare professional. 27th ed. Greenwood Village (CO): Thomson Micromedex; 2007.
   Google Scholar
• Forssell H, Tasmuth T, Tenovuo O, et al. Venlafaxine in the treatment of atypical facial pain: a randomized controlled trial. J Orofac Pain. 2004;18:131–137.
   PubMed Web of Science ®Google Scholar
• Ozyalcin SN, Talu GK, Kiziltan E, et al. The efficacy and safety of venlafaxine in the prophylaxis of migraine. Headache. 2005;45:144–152.
   PubMed Web of Science ®Google Scholar
• Cegielska-Perun K, Bujalska-Zadrożny M, Tatarkiewicz J, et al. Venlafaxine and neuropathic pain. Pharmacology. 2013;91:69–76.
   PubMed Web of Science ®Google Scholar
• Gallagher HC1, Gallagher RM, Butler M, et al. Venlafaxine for neuropathic pain in adults. Cochrane Database Syst Rev. 2015;8:CD011091.
   PubMed Web of Science ®Google Scholar
• Fava M, Mallinckrodt CH, Detke MJ, et al. The effect of duloxetine on painful physical symptoms in depressed patients: do improvements in these symptoms result in higher remission rates? J Clin Psychiatry. 2004;65:521–530.
   PubMed Web of Science ®Google Scholar
• Arnold LM, Rosen A, Pritchett YL, et al. A randomized, double-blind, placebo-controlled trial of duloxetine in the treatment of women with fibromyalgia with or without major depressive disorder. Pain. 2005;119:5–15.
   PubMed Web of Science ®Google Scholar
• Anttila SA, Leinonen EV. A review of the pharmacological and clinical profile of mirtazapine. CNS Drug Rev. 2001;7:249–264.
   PubMedGoogle Scholar
• Freynhagen R, Muth-Selbach U, Lipfert P, et al. The effect of mirtazapine in patients with chronic pain and concomitant depression. Curr Med Res Opin. 2006;22:257–264.
   PubMed Web of Science ®Google Scholar
• Bendtsen L, Evers S, Linde M, et al. EFNS guideline on the treatment of tension-type headache - report of an EFNS task force. Eur J Neurol. 2010;17:1318–1325.
   PubMed Web of Science ®Google Scholar
• Enomoto T1, Yamashita A, Torigoe K, et al. Effects of mirtazapine on sleep disturbance under neuropathic pain-like state. Synapse. 2012;66:483–488.
   PubMed Web of Science ®Google Scholar
• Samborski W, Lezanska-Szpera M, Rybakowski JK. Open trial of mirtazapine in patients with fibromyalgia. Pharmacopsychiatry. 2004;37:168–170.
   PubMed Web of Science ®Google Scholar
• Khouzam RH. Chronic pain and its management in primary care. South Med J. 2000;93:946–952.
   PubMed Web of Science ®Google Scholar
• Sarzi-Puttini P, Buskila D, Carrabba M, et al. Treatment strategy in fibromyalgia syndrome: where are we now? Semin Arthritis Rheum. 2008;37:353–365.
   PubMed Web of Science ®Google Scholar
• Mika J, Zychowska M, Makuch W, et al. Neuronal and immunological basis of action of antidepressants in chronic pain - clinical and experimental studies. Pharmacol Rep. 2013;65:1611–1621.
   PubMed Web of Science ®Google Scholar
• Khouzam HR. The antidepressant nefazodone. A review of its pharmacology, clinical efficacy, adverse effects, dosage, and administration. J Psychosoc Nurs Ment Health Serv. 2000;38:20–25.
   PubMedGoogle Scholar
• Shah TH, Moradimehr A. Bupropion for the treatment of neuropathic pain. Am J Hosp Palliat Care. 2010;27:333–336.
   PubMed Web of Science ®Google Scholar
• Belson MG, Kelley TR. Bupropion exposures: clinical manifestations and medical outcome. J Emerg Med. 2002;23:223–230.
   PubMed Web of Science ®Google Scholar
• Shepherd G, Velez LI, Keyes DC. Intentional bupropion overdoses. J Emerg Med. 2004;27:147–151.
   PubMed Web of Science ®Google Scholar
• Nogrady B. Neurobiology: life beyond the pain. Nature. 2014;515:SS8–9.
   Web of Science ®Google Scholar
• Rico-Villademoros F, Calandre EP, Slim M. Current status of atypical antipsychotics for the treatment of fibromyalgia. Drugs Today (Barc). 2014;50:435–444.
   PubMed Web of Science ®Google Scholar
• Maher AR, Maglione M, Bagley S, et al. Efficacy and comparative effectiveness of atypical antipsychotic medications for off-label uses in adults: a systematic review and meta-analysis. JAMA. 2011;306:1359–1369.
   PubMed Web of Science ®Google Scholar
• Alexander GC, Gallagher SA, Mascola A, et al. Increasing off-label use of antipsychotic medications in the United States, 1995–2008. Pharmacoepidemiol Drug Saf. 2011;20:177–184.
   PubMed Web of Science ®Google Scholar
• Seidel S, Aigner M, Ossege M, et al. Antipsychotics for acute and chronic pain in adults. J Pain Symptom Manage. 2010;39:768–778.
   PubMed Web of Science ®Google Scholar
• Maglione M, Ruelaz Maher A, Hu J, et al. Off label use of atypical antipsychotics: an update. Comparative Effectiveness Review No 43. Rockville (MD): Agency for Healthcare Research and Quality; September 2011. Available from: www.effectivehealthcare.ahrq.gov/reports/final/cfm.
   Google Scholar
• Davis JM, Chen N, Glick ID. A meta-analysis of the efficacy of second-generation antipsychotics. Arch Gen Psychiatry. 2003;60:553–564.
   PubMed Web of Science ®Google Scholar
• Calandre EP, Rico-Villademoros F. The role of antipsychotics in the management of fibromyalgia. CNS Drugs. 2012;26:135–153.
   PubMed Web of Science ®Google Scholar
• Devulapalli K, Nasrallah HA. An analysis of the high psychotropic off-label use in psychiatric disorders: the majority of psychiatric diagnoses have no approved drug. Asian J Psychiatry. 2009;2:29–36.
   PubMedGoogle Scholar
• Rico-Villademoros F, Hidalgo J, Dominguez I, et al. Atypical antipsychotics in the treatment of fibromyalgia: a case series with olanzapine. Prog Neuropsychopharmacol Biol Psychiatry. 2005;29:161–164.
   PubMed Web of Science ®Google Scholar
• Sharpley AL, Vassallo CM, Cowen PJ. Olanzapine increases slow-wave sleep: evidence for blockade of central 5-HT(2C) receptors in vivo. Biol Psychiatry. 2000;47:468–470.
   PubMed Web of Science ®Google Scholar
• McIntyre A, Paisley D, Kouassi E, et al. Quetiapine fumarate extended-release for the treatment of major depression with comorbid fibromyalgia syndrome: a double-blind, randomized, placebo-controlled study. Arthritis Rheumatol. 2014;66:451–461.
   PubMed Web of Science ®Google Scholar
• Seeman P. Atypical antipsychotics: mechanism of action. Can J Psychiatry. 2002;47:27–38.
   PubMed Web of Science ®Google Scholar
• Sansone RA, Sansone LA. Is Seroquel developing an illicit reputation for misuse/abuse? Psychiatry (Edgmont). 2010;7:13–16.
   PubMedGoogle Scholar
• Calandre EP1, Hidalgo J, Rico-Villademoros F. Use of ziprasidone in patients with fibromyalgia: a case series. Rheumatol Int. 2007;27:473–476.
   PubMed Web of Science ®Google Scholar
• Sernyak MJ, Leslie DL, Alarcon RD. Association of diabetes mellitus with use of atypical neuroleptics in the treatment of schizophrenia. Am J Psychiatry. 2002;159:561–566.
   PubMed Web of Science ®Google Scholar
• Werner FM, Coveñas R. Safety of antipsychotic drugs: focus on therapeutic and adverse effects. Expert Opin Drug Saf. 2014;13:1031–1042. http://www.ncbi.nlm.nih.gov/pubmed/24975932.
   PubMed Web of Science ®Google Scholar
• Kasahara S, Kunii Y, Mashiko H, et al. Four cases of chronic pain that improved dramatically following low-dose aripiprazole administration. Prim Care Companion CNS Disord. 2011;13:2.
   PubMedGoogle Scholar
• Sharma A, Sorrell JH. Aripiprazole-induced Parkinsonism. Int Clin Psychopharmacol. 2006;21:127–129.
   PubMed Web of Science ®Google Scholar
• Nelson S, Leung JG. Torsades de pointes after administration of low-dose aripiprazole. Ann Pharmacother. 2013;47(2):e11.
   PubMed Web of Science ®Google Scholar